4 completed. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Robert Koch Institut: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proactive Automatized Lifestyle Intervention Proactive Automatized Lifestyle intervention - Health Risk Behaviors | Not applicable | Completed | University Medicine Greifswald | 175 | 2022-05-31 | 2023-07-03 |
| Incidence of Diabetes After a COVID-19 Infection no interventional study - COVID-19, Diabetes Mellitus | Completed | InGef - Institute for Applied Health Research Berlin GmbH | 157134 | 2018-01-01 | 2024-03-25 | |
| A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine FLU-v, adjuvanted FLU-v, Saline - Influenza | Phase 2 | Completed | PepTcell Limited | 175 | 2016-08-01 | 2020-09-16 |
| Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza Masks, Masks & hand hygiene, Control - Influenza | Not applicable | Completed | Robert Koch Institut | 300 | 2009-01-01 | 2011-04-22 |
Influenza, Human (2) · COVID-19 (1) · Diabetes Mellitus (1) · Health Risk Behaviors (1) · Post-Acute COVID-19 Syndrome (1)
Hand Hygiene (1) · Masks (1) · Sodium Chloride (1)
Germany (3) · Netherlands (1)
Christa Scheidt-Nave, Dr. (1) · Jennis Freyer-Adam, Prof. Dr. (1) · Jochen Schmitt, Prof. Dr. med. (1) · Josephine Jacob, MSc (1) · Lukas Reitzle, Dr. (1) · Paul Groeneveld, PhD (1) · Ulrich John, Prof. Dr. (1)
PMID 22280120, PMID 32150750, PMID 33215698, PMID 36123081, PMID 36715243, PMID 39425090, PMID 40101761, PMID 40988066
2015 (1)